+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Oxidative stress and cardiovascular complications in polycystic ovarian syndrome

Oxidative stress and cardiovascular complications in polycystic ovarian syndrome

European Journal of Obstetrics, Gynecology, and Reproductive Biology 191: 15-22

Polycystic ovarian syndrome (PCOS) is a complex endocrine condition which is associated with metabolic and cardiovascular complications. It is elevated to a metabolic disorder with significant long term health ramification due to the high prevalence of insulin resistance (IR), impaired glucose tolerance, type 2 diabetes (T2D), dyslipidemia and numerous cardiovascular risk factors in PCOS women. This article concentrates on the recent developments in the regulation of oxidative stress (OS) in PCOS and on the association between PCOS and CVD outcomes. The prognostic events that define the severity of PCOS and involvement of cardiovascular risk in PCOS include endothelial dysfunction (ED) and impaired cardiac structure. Fact is that, in PCOS women, the circulating biomarkers of OS are in abnormal levels that are independent of overweight, which depicts the participation of OS in the pathophysiology of this common derangement. In addition, hyperglycemia (HG) per se, promotes reactive oxygen species (ROS) generation in PCOS. When the destructive ROS outbalances the concentration of physiological antioxidants, OS occurs. The resultant OS, directly stimulates hyperandrogenism and causes extensive cellular injury, DNA damage and/or cell apoptosis. To further the burden, the total serum antioxidant level in PCOS women is compromised, which diminishes the body's defense against an oxidative milieu. Thus, it is evident that OS regulates several cellular mechanisms in PCOS. Improving our understanding about the regulation of OS, critical role of ROS and protein biomarkers in PCOS should lead to novel therapeutic strategies in addressing PCOS-induced CVD. Besides, it is possible that the beneficial effects of dietary or therapeutic antioxidants have significant clinical relevance in PCOS.

(PDF emailed within 0-6 h: $19.90)

Accession: 058488897

Download citation: RISBibTeXText

PMID: 26066290

DOI: 10.1016/j.ejogrb.2015.05.005

Related references

Oxidative stress in non-obese women with polycystic ovarian syndrome. Journal of Clinical and Diagnostic Research 8(7): Cc01-Cc03, 2014

Oxidative stress and polycystic ovary syndrome: evaluation during ovarian stimulation for ICSI. Reproduction 2016, 2016

Polycystic ovarian syndrome is linked to increased oxidative stress in Omani women. International Journal of Women's Health 10: 763-771, 2018

Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clinical Biochemistry 34(5): 407-413, 2001

Evaluation of Oxidative Stress and hsCRP in Polycystic Ovarian Syndrome in a Tertiary Care Hospital. Indian Journal of Clinical Biochemistry 30(2): 161-166, 2015

Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination. Diabetes and Metabolic Syndrome 11 Suppl 2: S841-S851, 2017

Spironolactone and dimethylsulfoxide effect on glucose metabolism and oxidative stress markers in polycystic ovarian syndrome rat model. Experimental and Clinical Endocrinology and Diabetes 122(3): 154-162, 2014

Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecologic and Obstetric Investigation 69(3): 197-202, 2010

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertility & Sterility 80(1): 123-127, 2003

Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome. Reproductive Sciences 22(8): 942-947, 2016

Evaluation of Oxidative Stress in Women with Polycystic Ovarian Syndrome as Represented by Serum Ischemia Modified Albumin and Its Correlation with Testosterone and Insulin Resistance. Internal Medicine 55(17): 2359-2364, 2017

Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical, biochemical and oxidative stress considerations. Fundamental and Clinical Pharmacology 23(1): 59-67, 2009

Do cardiovascular risk factors in polycystic ovarian syndrome result in more cardiovascular events?. Journal of Clinical Endocrinology and Metabolism 93(4): 1170-1171, 2008

Is reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?. International Journal of Fertility and Sterility 5(2): 90-95, 2011

Effect of green tea on metabolic and hormonal aspect of polycystic ovarian syndrome in overweight and obese women suffering from polycystic ovarian syndrome: A clinical trial. Journal of Education and Health Promotion 6: 36, 2017